Chicago investor devises £250M deal as real estate grows with UK's biotech sector
Having snapped up a coveted spot at Kendall Square in Cambridge, MA for a reported $1 billion last year, Chicago-based real estate investor Harrison Street is eyeing several life sciences properties in the UK.
Harrison Street is partnering with London’s Trinity Investment Management for the £250 million ($328 million) deal, which would give them joint ownership of 1.6 million square feet of lab and office space, making them landlords of life sciences companies such as GW Pharmaceuticals, the Financial Times reported.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.